Table of Contents

• 1. Website
• 2. Name of journal
• 3. Peer review process
• 4. Ownership, journal management team, and publishing credentials
• 5. Governing body
• 6. Editorial team and contact information
• 7. Copyright and licensing
• 8. Article processing charges
• 9. Process for the identification of and dealing with allegations of research misconduct
• 10. Publication ethics
• 11. Publishing schedule
• 12. Access
• 13. Archiving
• 14. Revenue sources
• 15. Advertising
• 16. Direct marketing

1. Website

The official journal title is Journal of Trauma and Injury (abbreviated as J Trauma Inj or JTI).

2. Name of journal

The official journal title is Journal of Trauma and Injury. The abbreviated title is J Trauma Inj.

3. Peer review process

JTI has an online submission and peer review system at https://submit.jtraumainj.org. All papers, including those invited by the Editor, are subject to peer review. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. If the manuscript does not fit the aims and scope of the journal or does not adhere to the Instructions for Authors, it may be returned to the author immediately after receipt and without a review. Before reviewing, all submitted manuscripts are inspected by Similarity Check powered by iThenticate (https://www.crossref.org/services/similarity-check/), a plagiarism-screening tool.

All manuscripts from editors, employees, or members of the Editorial Board are processed the same way as other unsolicited manuscripts. During the review process, they will not engage in the selection of reviewers nor the decision process. Editors will not handle their own manuscripts even if they are commissioned ones.

The journal uses a double-blind peer-review process: the reviewers do not know the identity of the authors, and vice versa. All manuscripts undergo peer review by at least two reviewers with relevant expertise selected by the Editorial Board. A third reviewer will be assigned if there is a discrepancy between two reviewers. Authors will receive notification of the publication decision, along with copies of the reviews and instructions for revision, if appropriate, within two months after receipt of the submission.

The Editorial Board has the right to revise and edit the styles and structures of submitted manuscripts within the context if necessary. Once the decision on publication as accept, revision, or reject is made, it is directly notified to the corresponding author. After the final draft of manuscripts are proven to be appropriate according to the publication policies and styles of the journal, the decision of publication is finalized and expected publication date will be given. Rejected manuscripts are not to be considered again.

The decision to publish will be made by the Editorial Board of the journal after the peer review. JTI’s average turnaround time from submission to decision is 4 to 8 weeks. The Editor is responsible for the final decision whether the manuscript is accepted or rejected.

4. Ownership, journal management team, and publishing credentials

The journal is owned by the publisher, the Korean Society of Traumatology of the Republic of Korea (http://trauma.or.kr)

The full names and affiliations of the members of the journal management team are displayed on the About (Journal managing team) tab of the journal homepage.

5. Governing body

The governing body is the journal's Editorial Board.

6. Editorial team and contact information

The full names and affiliations of the journal’s editors are displayed on the About (Editorial Board) tab of the journal homepage, and the contact information for the Editor-in-Chief and the Editorial Office is on the About (Contact us) tab.

7. Copyright and licensing

Copyright policy: All published papers become the permanent property of the Korean Society of Traumatology. Copyrights of all published materials are owned by the Korean Society of Traumatology and permission must be obtained for any commercial use of materials. Every author must sign the Transfer of Copyright Agreement forms.

Licensing information: This is an open access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

8. Article processing charges

There are no author submission fees or other publication-related charges. All cost for the publication process is supported by the publisher. JTI is a so-called platinum open access journal which does not charge author fees.

9. Process for the identification of and dealing with allegations of research misconduct

When the journal faces suspected cases of research and publication misconduct, such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (COPE) (http://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are carried out by the Editorial Board.

10. Publication ethics

JTI follows the Guideline on Good Publication of COPE (https://publicationethics.org), Recommendations of International Committee of Medical Journal Editors (http://www.icmje.org/recommendations), and Good Publication Practice Guidelines for Medical Journals of Korean Association of Medical Journal Editors (http://kamje.or.kr). Our publication ethics are displayed on the Editorial Policy (Publication ethics) tab of journal homepage.

11. Publishing schedule

JTI is published quarterly on the last day of every March, June, September, and December. Any supplementary or special issues may be published.

12. Access

JTI is freely accessible from http://www.jtraumainj.org according to the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/). The copyright, including the right of online transmission, is owned by the Korean Society of Traumatology.

13. Archiving

JTI is accessible without barrier from Korea Citation Index and is archived in the National Library of Korea in the event the journal is no longer published.

14. Revenues sources

Revenue sources of the journal are from the support of the publisher, the Korean Society of Traumatology, and the support of the Korean Federation of Science and Technology Societies grant funded by the Korean government (Ministry of Science and ICT).

15. Advertising

JTI currently does not operate advertised products or services.

16. Direct marketing

Journal propagation has been done through the journal website and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on presenters at conferences, seminars, or workshops related to the journal's aims and scope.